| Literature DB >> 25955522 |
Beatrice Chipwaza1, Ginethon G Mhamphi2, Steve D Ngatunga3, Majige Selemani4, Mbaraka Amuri5, Joseph P Mugasa6, Paul S Gwakisa7.
Abstract
INTRODUCTION: Bacterial etiologies of non-malaria febrile illnesses have significantly become important due to high mortality and morbidity, particularly in children. Despite their importance, there are few reports on the epidemiology of these diseases in Tanzania, and the true burden of such illnesses remains unknown. This study aimed to identify the prevalence of leptospirosis, brucellosis, typhoid fever and urinary tract infections and their rate of co-infections with malaria.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25955522 PMCID: PMC4425467 DOI: 10.1371/journal.pntd.0003750
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Map of Tanzania showing the study area.
Patients’ demographic and enrollment characteristics (N = 370).
| Characteristic | n (%) | |
|---|---|---|
|
| Male | 189 (51.1) |
| Female | 181 (48.9) | |
|
| < 5 years | 205 (55.4) |
| ≥5 years | 165 (44.6) | |
|
| Wet season | 189 (51.1) |
| Dry season | 181 (48.9) | |
|
| Mild fever | 280 (75.7) |
| Moderate fever | 85 (23.0) | |
| High fever | 5 (1.3) | |
|
| No recent therapy | 266 (71.9) |
| Anti-malarials | 75 (20.3) | |
| Antibacterials | 11 (2.9) | |
| Anti-malarials & antibiotics | 18 (4.9) |
Prevalence of malaria and bacterial febrile illnesses, the diagnosis and the prescribed treatment.
| Subcategory | Malaria n/N (%) | Presumptive acute leptospirosis n/N (%) | Probable prior leptospirosis n/N (%) | Confirmed leptospirosis n/N (%) | Presumptive acute brucellosis n/N (%) | Probable prior brucellosis n/N (%) |
|
| PresumptiveTyphoid fever n/N (%) |
|---|---|---|---|---|---|---|---|---|---|
|
| 85/370 (23.0) | 43/370 (11.6) | 16/370 (4.3) | 26/200 (13) | 26/370 (7.0) | 42/370 (11.4) | 26/370 (7.0) | 57/370 (15.4) | 38/370 (10.3) |
|
| 45/189 (23.8) | 16/189 (8.5) | 10/189 (5.3) | 17/89 (19.1) | 13/189 (6.9) | 13/189 (6.9) | 13/189 (6.9) | 22/189 (11.6) | 13/189 (6.9) |
|
| 40/181 (22.1) | 27/181 (14.9) | 6/181 (3.3) | 9/111 (8.1) | 13/181 (7.2) | 29/181 (16.0) | 13/181 (7.2) | 35/181 (19.3) | 25/181 (13.8) |
|
| 47/205 (22.9) | 16/205 (7.8) | 9/205 (4.4) | 13/111 (11.7) | 6/205 (2.9) | 13/205 (6.3) | 12/205 (5.9) | 9/205 (4.4) | 14/205 (6.8) |
|
| 38/165 (23.0) | 27/165 (16.4) | 7/165 (4.2) | 13/89 (14.6) | 20/165 (12.1) | 29/165 (17.6) | 14/165 (8.5) | 48/165 (29.1) | 24/165 (14.5) |
|
| 37/189 (19.6) | 30/189 (15.9) | 16/189 (8.5) | 14/84 (16.7) | 19/189 (10.1) | 28/189 (14.8) | 18/189 (9.5) | 38/189 (20.1) | 20/189 (10.6) |
|
| 48/181 (26.5) | 13/181 (7.2) | 0 | 12/116 (10.3) | 7/181 (3.9) | 14/181 (7.7) | 8/181 (4.4) | 19/181 (10.5) | 18/181 (9.9) |
|
| |||||||||
| Diarrhea | 5/85 (5.9) | 1/43 (2.3) | 1/16 (6.3) | 0 | 2/26 (7.7) | 4/42 (9.5) | 4/26 (15.4) | 0 | 4/38 (10.5) |
| Vomiting | 30/85 (35.3) | 8/43 (18.6) | 3/16 (18.8) | 5/26 (19.2) | 4/26 (15.4) | 8/42 (19.1) | 4/26 (15.4) | 6/57 (10.5) | 9/38 (23.7) |
| Loss of appetite | 14/85 (16.5) | 3/43 (7.0) | 4/16 (25.0) | 2/26 (7.7) | 5/26 (19.2) | 10/42 (23.8) | 4/26 (15.4) | 5/57 (8.8) | 3/38 (7.9) |
| Joint pain | 3/85 (3.5) | 3/43 (7.0) | 0 | 1/26 (3.8) | 1/26 (3.9) | 8/42 (19.0) | 7/26 (26.9) | 4/57 (7.0) | 1/38 (2.6) |
| Abdominal pain | 15/85 (17.7) | 6/43 (14.0) | 5/16 (31.3) | 3/26 (11.5) | 4/26 (15.4) | 3/42 (7.1) | 1/26 (3.9) | 10/57 (17.5) | 9/38 (23.7) |
| Headache | 8/85 (9.4) | 10/43 (23.3) | 1/16 (6.3) | 7/26 (26.9) | 2/26 (7.7) | 4/42 (9.5) | 3/26 (11.5) | 5/57 (8.8) | 2/38 (5.3) |
| Other symptoms | 5/85 (5.9) | 7/43 (16.3) | 2/16 (12.5) | 6/26 (23.1) | 3/26 (11.5) | 4/42 (9.5) | 2/26 (7.7) | 8/57 (14.0) | 2/38 (5.3) |
|
| |||||||||
| Malaria | 85/85 (100) | 13/43 (30.2) | 2/16 (12.5) | 7/26 (26.9) | 3/26 (11.5) | 8/42 (19.0) | 3/26 (11.5) | 9/57 (15.8) | 13/38 (34.2) |
| UTI | 25/85 (29.4) | 22/43 (51.2) | 9/16 (56.3) | 11/26 (42.3) | 14/26 (53.8) | 21/42 (50.0) | 9/26 (34.6) | 35/57 (61.4) | 17/38 (44.7) |
| Pneumonia | 3/85 (3.5) | 5/43 (11.6) | 1/16 (6.3) | 2/26 (7.7) | 6/26 (23.1) | 7/42 (16.7) | 7/26 (26.9) | 5/57 (8.8) | 2/38 (5.3) |
| URT | 0 | 2/43 (4.7) | 5/16 (31.3) | 0 | 1/26 (3.9) | 0 | 1/26 (3.8) | 2/57 (3.5) | 2/38 (5.3) |
| Other infections | 1/85 (1.2) | 7/43 (16.3) | 0 | 6/26 (23.1) | 5/26 (19.2) | 7/42 (16.7) | 4/26 (15.4) | 10/57 (17.5) | 5/38 (13.2) |
|
| |||||||||
| Anti-malarials | 85/85 (100) | 13/43 (30.2) | 2/16 (12.5) | 7/26 (26.9) | 3/26 (11.5) | 7/42 (16.7) | 3/26 (11.5) | 9/57 (15.8) | 13/38 (34.2) |
| Antibacterials | 34/85 (40) | 35/43 (81.4) | 15/16 (93.8) | 21/26 (80.8) | 25/26 (96.2) | 35/42 (83.3) | 24/26 (92.3) | 51/57 (89.5) | 31/38 (81.6) |
| Antipyretics | 74/85 (87.1) | 31/43 (72.1) | 9/16 (56.3) | 17/26 (65.4) | 17/26 (65.4) | 27/42 (64.3) | 19/26 (73.1) | 42/57 (73.7) | 31/38 (81.6) |
| Other drugs | 1/85 (1.2) | 5/43 (11.6) | 1/16 (6.3) | 5/26 (19.2) | 5/26 (19.2) | 11/42 (26.2) | 3/26 (11.5) | 8/57 (14.0) | 7/38 (18.4) |
* Nasal discharge, cough, skin rashes, swollen tonsils, ear pain (discharge) and muscle aches;
§ UTR = Upper respiratory tract infections;
Chicken pox, boils, otitis media, enteric fever, herpes simplex, rhinitis and dysentery;
Paediatric zinc, prednisolone, vitamins, ORS (oral rehydration salts) and antihelmintics.
The association of febrile illnesses with sex, age and season.
| Odds Ratio | 95%CI | P-value | ||
|---|---|---|---|---|
|
| Male | 1.00 | ||
| Female | 0.90 | 0.55–1.46 | 0.661 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 1.09 | 0.66–1.79 | 0.744 | |
| Wet season | 1.00 | |||
| Dry season | 1.53 | 0.92–2.53 | 0.097 | |
|
| Male | 1.00 | ||
| Female | 1.91 | 0.98–3.75 | 0.059 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 1.87 | 0.95–3.68 | 0.072 | |
| Wet season | 1.00 | |||
| Dry season | 0.42 | 0.21–0.86 | 0.017 | |
|
| Male | 1.00 | ||
| Female | 0.37 | 0.15–0.88 | 0.025 | |
| <5 years | 1.00 | |||
| ≥ 5 years | 1.29 | 0.56–2.94 | 0.546 | |
| Wet season | 1.00 | |||
| Dry season | 0.58 | 0.25–1.32 | 0.193 | |
|
| Male | 1.00 | ||
| Female | 0.97 | 0.42–2.21 | 0.939 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 3.84 | 1.48–10.01 | 0.006 | |
| Wet season | 1.00 | |||
| Dry season | 0.40 | 0.16–1.01 | 0.051 | |
|
| Male | 1.00 | ||
| Female | 2.51 | 1.24–5.07 | 0.010 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 2.78 | 1.37–5.66 | 0.005 | |
| Wet season | 1.00 | |||
| Dry season | 0.57 | 0.28–1.15 | 0.117 | |
|
| Male | 1.00 | ||
| Female | 1.78 | 0.96–3.31 | 0.067 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 8.02 | 3.76–17.11 | <0.001 | |
| Wet season | 1.00 | |||
| Dry season | 0.60 | 0.31–1.13 | 0.112 | |
|
| Male | 1.00 | ||
| Female | 1.04 | 0.46–2.33 | 0.928 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 1.25 | 0.55–2.84 | 0.598 | |
| Wet season | 1.00 | |||
| Dry season | 0.42 | 0.17–1.102 | 0.054 | |
|
| Male | 1.00 | ||
| Female | 3.02 | 1.70–5.34 | <0.001 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 1.12 | 0.66–1.95 | 0.685 | |
| Wet season | 1.00 | |||
| Dry season | 0.86 | 0.49–1.49 | 0.585 | |
|
| Male | 1.00 | ||
| Female | 2.38 | 1.14–4.98 | 0.021 | |
| < 5 years | 1.00 | |||
| ≥ 5 years | 2.20 | 1.06–4.57 | 0.034 | |
| Wet season | 1.00 | |||
| Dry season | 1.11 | 0.54–2.28 | 0.781 |
The commonly prescribed antibacterial drugs.
| Amoxicillin n/N (%) | Ampicillin n/N (%) | Co-trimoxazole n/N (%) | Crystapen n/N (%) | Gentamycin n/N (%) | Ciprofloxacin n/N (%) | Erythromycin n/N (%) | Other antibiotics | |
|---|---|---|---|---|---|---|---|---|
| Malaria | 6/34 (17.6) | 0 | 26/34 (76.5) | 2/34 (5.9) | 0 | 0 | 1/34 (2.9) | 0 |
| Presumptive leptospirosis | 9/35 (25.7) | 1/35 (2.9) | 12/35 (34.3) | 5/35 (14.3) | 1/35 (2.9) | 4/35 (11.4) | 3/35 (8.6) | 5/35 (14.3) |
| Confirmed leptospirosis | 6/21 (28.6) | 1/21 (4.8) | 6/21 (28.6) | 2/21 (9.5) | 1/21 (4.8) | 1/21 (4.8) | 2/21 (9.5) | 0 |
| Presumptive brucellosis | 5/25 (20.0) | 0 | 11/25 (44.0) | 3/25 (12.0) | 1/25 (4.0) | 1/25 (4.0) | 1/25 (4.0) | 6/25 (24.0) |
| Probable prior brucellosis | 8/35 (22.9) | 0 | 16/35 (45.7) | 3/35 (8.6) | 1/35 (2.9) | 0 | 2/35 (5.7) | 8/35 (22.9) |
|
| 10/24 (41.7) | 0 | 6/24 (25.0) | 5/24 (20.8) | 1/24 (4.2) | 0 | 2/24 (8.3) | 5/24 (20.8) |
|
| 9/51 (17.6) | 3/51 (5.9) | 19/51 (37.3) | 3/51 (5.9) | 3/51 (5.9) | 2/51 (3.9) | 4/51 (7.8) | 10/51 (19.6) |
| Presumptive typhoid fever | 6/31 (19.4) | 1/31 (3.2) | 12/31 (38.7) | 4/31 (12.9) | 2/31 (6.5) | 2/31 (6.5) | 1/31 (3.2) | 7/31 (22.6) |
| Urinary tract infection | 8/64 (12.5) | 2/64 (3.1) | 45/64 (70.3) | 9/64 (14.1) | 3/64 (4.7) | 0 | 2/64 (3.1) | 5/64 (7.8) |
ξ Chloramphenical, cloxacillin, and Tetracycline
Summary for the occurrence of multiple infections (N = 370).
| Disease | n (%) |
|---|---|
| Prevalence of multiple infections | 146(39.5) |
|
|
|
| Malaria + UTI | 12 (3.2) |
| Malaria + typhoid fever | 13 (3.5) |
| Malaria + presumptive leptospirosis | 13 (3.5) |
| Malaria + confirmed leptospirosis | 7 (1.9) |
| Malaria + presumptive brucellosis | 3 (0.8) |
| Malaria + probable prior | 7 (1.9) |
| Malaria + | 3 (0.8) |
| Malaria + | 9 (2.4) |
| UTI + typhoid fever | 8 (2.2) |
| UTI + confirmed leptospirosis | 6 (1.6) |
| UTI + | 14 (3.8) |
| UTI + | 5 (1.4) |
| Typhoid + | 11 (3.0) |
| Typhoid + | 5 (1.4) |
| Typhoid + confirmed leptospirosis | 9 (2.4) |
|
|
|
| Malaria + UTI + typhoid fever | 3 (0.8) |
| Malaria + UTI + | 4 (1.1) |
| Malaria + typhoid + confirmed leptospirosis | 2 (0.6) |
| UTI + Typhoid + | 3 (0.8) |
| UTI + typhoid + confirmed leptospirosis | 2 (0.6) |
| UTI + confirmed leptospirosis + | 2 (0.6) |
| Typhoid + confirmed leptospirosis + | 4 (1.1) |